Britain’s most senior healthcare official has dealt the cannabis market a blow by revealing grave issues about the rollout of medicinal marijuana.

The UK legalized cannabis for medicinal purposes towards the finish of 2018, but “cruel and ridiculous” NHS recommendations have prevented medical doctors from prescribing it for all but a handful of individuals. The government is beneath stress from several MPs, individuals, and parents of suffering young children to unwind its stance and let a appropriate market to flourish.

Having said that, NHS England chief executive Simon Stevens gave a speech to 300 medical doctors this week and revealed that he is not considerably of a fan of medicinal cannabis. “We have to be cautious, as we have a reputable national debate on health-related cannabis, that we do not appear back in a decade’s time and wonder irrespective of whether we inadvertently produced a massive error,” he stated.

He pointed to the “well documented health-related risks” from “so-known as recreational cannabis” and stated the government should really be wary of “accidentally normalising drug use”. Stevens warned that medicinal cannabis could merely prove a gateway to adult-use legalization, which he opposes.

He revealed that he has just returned from a trip to North America and warned colleagues of a complete market chomping at the bit to expand its tentacles into Britain.

The UK is the world’s fifth biggest economy and it has the prospective to be a big industry for medicinal cannabis.

It is currently massive small business in the nation, as it is one particular of the world’s biggest exporters of health-related marijuana, thanks largely to British Sugar’s cultivation operation in Norfolk and the international good results enjoyed by GW Pharmaceuticals (NASDAQ: GWPH).

The firm’s biggest investor is Capital Group, which employs the Prime Minister’s husband, Philip May well, as a partnership manager.

Campaigners for the liberalization of cannabis laws in Britain locate this scenario to reek of hypocrisy, and they continue to pile stress on the NHS to alter its recommendations, which had been devised by the Royal College of Physicians and The British Paediatric Neurology Association.

Stevens did admit that there is a want to conduct investigation into the clinical makes use of of medicinal cannabis, despite the fact that his comments will come as a blow to activists across the UK.